Gilenya (generic name fingolimod) can cause an increase in blood pressure, including the development of high blood pressure (hypertension), in some patients. Clinical studies have shown that patients taking Gilenya experienced an average rise in systolic blood pressure of about…
Gilenya (fingolimod) is a medication used to treat relapsing forms of multiple sclerosis (MS), a disease that often affects women of childbearing age. When considering its safety for this group, several important factors must be understood about the drug’s effects…
Gilenya, known generically as fingolimod, is a medication primarily used to treat multiple sclerosis (MS) by modulating the immune system. Because it affects immune function, understanding its interactions with other drugs, including antibiotics, is important for safe and effective treatment.…
Gilenya (fingolimod) is a medication primarily used to treat multiple sclerosis (MS), and it has been associated with certain eye-related side effects, particularly **macular edema**, which can cause vision problems. Macular edema is swelling or thickening of the macula, the…
Gilenya, known generically as fingolimod, is a medication primarily used to treat relapsing forms of multiple sclerosis (MS). One important concern for patients and healthcare providers is whether Gilenya increases the risk of cancer, particularly skin cancers and lymphomas. Gilenya…
Aubagio, whose active ingredient is teriflunomide, is a medication prescribed primarily for treating relapsing forms of multiple sclerosis (MS). The FDA warnings on Aubagio highlight several important safety concerns and potential adverse effects that patients and healthcare providers must carefully…
Aubagio is a medication specifically designed to help people with multiple sclerosis (MS) by reducing the frequency of relapses. Relapses in MS are episodes where symptoms suddenly worsen or new symptoms appear, caused by inflammation and damage to the nervous…
Aubagio, a medication used to treat multiple sclerosis (MS), can indeed cause mood changes in some people. While it is primarily prescribed to reduce relapse frequency and slow disability progression in MS, mood alterations such as depression, anxiety, irritability, or…
Aubagio, whose active ingredient is teriflunomide, is a medication commonly prescribed to treat relapsing forms of multiple sclerosis (MS). It works by modulating the immune system to reduce inflammation and slow disease progression. However, like many medications affecting the nervous…
If you stop taking Aubagio (teriflunomide) suddenly, several important things can happen that affect your health and the management of multiple sclerosis (MS). Aubagio is a disease-modifying therapy designed to reduce MS relapses and slow progression by modulating the immune…